✨
AI Summary
- George Yancopoulos, president of Regeneron, discusses the emergence and characteristics of the Omicron variant of COVID-19
- Topics include viral mutation, variant transmission, and biomedical responses to new threats
- Episode provides expert analysis on pandemic developments and pharmaceutical industry insights